Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia (original) (raw)

Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia

Antonella Calogero

Blood, 1983

View PDFchevron_right

Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression

Ali Turhan

Blood, 2002

View PDFchevron_right

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

Emanuela Marcenaro

Blood, 2002

View PDFchevron_right

The antileukemic potential of natural killer cells

Nadia Peragine

Immunotherapy, 2016

View PDFchevron_right

Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-α-2b treatment

Marianne Hokland

Leukemia Research, 1989

View PDFchevron_right

Generation of non MHC restricted killing in non-cytotoxic T-lymphocytes from leukaemia patients

María del Luján Cardoso

British Journal of Haematology, 1987

View PDFchevron_right

Natural killer cell cytotoxic activity: measurement of the apoptotic inducing mechanisms

Sonya Marshall-Gradisnik

Clinical and Experimental Medical Sciences, 2013

View PDFchevron_right

Influence of tumor cells on natural killer cell phenotype and cytotoxicity

Aikyn Kali

International Journal of Biology, 2015

View PDFchevron_right

Defects of natural killer cell activity in children with untreated acute lymphocytic leukemia

Jelka Gabrilovac

Klinische Wochenschrift, 1988

View PDFchevron_right

Acute Leukemia and Nonspecific Killer Cells

Peter Jantscheff

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, 1981

View PDFchevron_right

Natural cytotoxicity to human leukemia mediated by mouse non-t cells

Hans Wigzell

International Journal of Cancer, 1977

View PDFchevron_right

Clinical significance of natural killer cell cytotoxicity: Need for proper data analysis in the design of clinical studies

James Rusthoven

European Journal of Cancer and Clinical Oncology, 1985

View PDFchevron_right

Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets

Steven Pincus, Joseph Locker, Edward Ball, Lucia da Rocha Silla

British Journal of Haematology, 1996

View PDFchevron_right

Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes

Franco Pandolfi

Leukemia Research, 1989

View PDFchevron_right

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies

Jean-Charles Grivel

Frontiers in Immunology, 2015

View PDFchevron_right

Target-cell-induced anergy in natural killer cells: suppression of cytotoxic function

Ashok Khar

Cancer Immunology, Immunotherapy, 2000

View PDFchevron_right

Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade

Michelle Gleason

Biology of Blood and Marrow Transplantation, 2010

View PDFchevron_right

Functional evaluation of natural killer cell cytotoxic activity in NFKB2-mutated patients

Francesco Licciardi

Immunology letters, 2017

View PDFchevron_right

Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer

Carlos Alfaro

Expert Opinion on Biological Therapy, 2007

View PDFchevron_right

Natural killer cell activity in a population of leukemia-prone wild mice (mus musculus)

Suraiya Rasheed

International Journal of Cancer, 1981

View PDFchevron_right

Natural Killer (NK) Cell Alloreactivities Against Leukemic Cells: Functions Beyond Defense

Suwit Chaisri

Cancer Immunotherapy and Biological Cancer Treatments, 2019

View PDFchevron_right

Human NK receptors: From the molecules to the therapy of high risk leukemias

Simona Sivori

FEBS Letters, 2011

View PDFchevron_right

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

D. Rollison

…, 2007

View PDFchevron_right

Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations

Francisco Bonilla

Journal of Clinical Investigation, 2002

View PDFchevron_right

Natural killer and lymphokine-activated killer cell functions in chronic myeloid leukemia

Abdul Rehman Fakih

Cancer Immunology Immunotherapy, 1990

View PDFchevron_right

The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions

Maurizio Provenzano

Blood, 2005

View PDFchevron_right

Human Choriocarcinoma Cell Resistance to Natural Killer Lysis Due to Defective Triggering of Natural Killer Cells

Gilles Thibault

Biology of Reproduction, 2003

View PDFchevron_right

Relevance of target cell-induced apoptosis as mechanism of resistance against natural killer cells

Gerald Wulf

Annals of Hematology, 2010

View PDFchevron_right